UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Wireless TENS for Peripheral Edema (Lower Limb Swelling)

Phase 1

Active, not recruiting

Conditions: Peripheral Edema

Interventions: Device: Transcutaneous Electrical Nerve Stimulation (TENS)

First Posted Date: 2020-12-23

Last Posted Date: 2023-08-09

Lead Sponsor: University of Rochester

Target Recruit Count: 52

Registration Number: NCT04680533

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Network Intervention to Prevent Vaping

Not Applicable

Active, not recruiting

Conditions: Social Networking
Vaping
Preventive Psychiatry

Interventions: Behavioral: Above the Influence-Vaping (ATI-V)

First Posted Date: 2020-12-21

Last Posted Date: 2025-04-11

Lead Sponsor: University of Rochester

Target Recruit Count: 3840

Registration Number: NCT04678245

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

An Online Cognitive Assessment in Cancer Patients

Not Applicable

Completed

Conditions: Cancer-Related Cognitive Impairment
Cancer-Related Cognitive Difficulties

Interventions: Behavioral: CAMPFIRE Online Cognitive Assessment for Cancer Patients

First Posted Date: 2020-12-16

Last Posted Date: 2024-04-01

Lead Sponsor: University of Rochester

Target Recruit Count: 31

Registration Number: NCT04667689

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

Not Applicable

Completed

Conditions: Cognitive Impairment
Cancer-related Problem/Condition

Interventions: Behavioral: MAAT-G
Behavioral: Supportive therapy (time and attention control)

First Posted Date: 2020-12-16

Last Posted Date: 2024-05-06

Lead Sponsor: University of Rochester

Target Recruit Count: 85

Registration Number: NCT04669301

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

PROMIS and Patient Satisfaction

Not Applicable

Completed

Conditions: Ankle Pathology
Foot Pathology

Interventions: Behavioral: Placebo
Behavioral: PROMIS Score Explanation

First Posted Date: 2020-12-04

Last Posted Date: 2023-04-10

Lead Sponsor: University of Rochester

Target Recruit Count: 275

Registration Number: NCT04654910

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Osteopathic Manipulative Medicine to Reduce Developmental Delays

Not Applicable

Completed

Conditions: Extreme Prematurity
Neurodevelopmental Abnormality

Interventions: Other: Osteopathic Manipulative Medicine

First Posted Date: 2020-12-03

Last Posted Date: 2023-08-14

Lead Sponsor: University of Rochester

Target Recruit Count: 150

Registration Number: NCT04652063

Locations: 🇺🇸
Golisano Children's Hospital, Rochester, New York, United States
🇺🇸
University of Rochester, Rochester, New York, United States

A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Not Applicable

Recruiting

Conditions: Prostate Cancer
HDR

Interventions: Procedure: High-Dose-Rate Brachytherapy

First Posted Date: 2020-11-27

Last Posted Date: 2024-08-06

Lead Sponsor: University of Rochester

Target Recruit Count: 12

Registration Number: NCT04645810

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Daratumumab
Drug: Lenalidomide
Drug: Dexamethasone

First Posted Date: 2020-11-19

Last Posted Date: 2024-07-09

Lead Sponsor: University of Rochester

Target Recruit Count: 28

Registration Number: NCT04635189

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists

Not Applicable

Completed

Conditions: Acute Myeloid Leukemia

First Posted Date: 2020-11-12

Last Posted Date: 2025-04-01

Lead Sponsor: University of Rochester

Target Recruit Count: 15

Registration Number: NCT04625413

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring

Not Applicable

Completed

Conditions: Acne Scars - Mixed Atrophic and Hypertrophic

Interventions: Device: Hybrid fractional laser
Other: Alastin Regenerating Skin Nectar with TriHex Technology
Other: Cetaphil face cream

First Posted Date: 2020-10-28

Last Posted Date: 2023-04-13

Lead Sponsor: University of Rochester

Target Recruit Count: 10

Registration Number: NCT04606134

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Home Terms & Conditions Privacy Policy